Justin Mak1, Tina M Cowan2. 1. Clinical Biochemical Genetics Laboratory, Stanford Health Care, United States of America. Electronic address: jmak@stanfordhealthcare.org. 2. Clinical Biochemical Genetics Laboratory, Stanford Health Care, United States of America; Department of Pathology, Stanford University Medical Center, United States of America.
Abstract
BACKGROUND: Urine and plasma biomarker testing for lysosomal storage disorders by liquid chromatography mass spectrometry (LC-MS) currently requires multiple analytical methods to detect the abnormal accumulation of oligosaccharides, mucopolysaccharides, and glycolipids. To improve clinical testing efficiency, we developed a single LC-MS method to simultaneously identify disorders of oligosaccharide, mucopolysaccharide, and glycolipid metabolism with minimal sample preparation. METHODS: We created a single chromatographic method for separating free glycans and glycolipids in their native form, using an amide column and high pH conditions. We used this glycomic profiling method both in untargeted analyses of patient and control urines using LC ion-mobility high-resolution MS (biomarker discovery), and targeted analyses of urine, serum, and dried blood spot samples by LC-MS/MS (clinical validation). RESULTS: Untargeted glycomic profiling revealed twenty biomarkers that could identify and subtype mucopolysaccharidoses. We incorporated these with known oligosaccharide and glycolipid biomarkers into a rapid test that identifies at least 27 lysosomal storage disorders, including oligosaccharidoses, mucopolysaccharidoses, sphingolipidoses, glycogen storage disorders, and congenital disorders of glycosylation and de-glycosylation. In a validation set containing 115 urine samples from patients with lysosomal storage disorders, all were unambiguously distinguished from normal controls, with correct disease subtyping for 88% (101/115) of cases. Glucosylsphingosine was reliably elevated in dried blood spots from Gaucher disease patients with baseline resolution from galactosylsphingosine. CONCLUSION: Glycomic profiling by liquid chromatography mass spectrometry identifies a range of lysosomal storage disorders. This test can be used in clinical evaluations to rapidly focus a diagnosis, as well as to clarify or support additional gene sequencing and enzyme studies.
BACKGROUND: Urine and plasma biomarker testing for lysosomal storage disorders by liquid chromatography mass spectrometry (LC-MS) currently requires multiple analytical methods to detect the abnormal accumulation of oligosaccharides, mucopolysaccharides, and glycolipids. To improve clinical testing efficiency, we developed a single LC-MS method to simultaneously identify disorders of oligosaccharide, mucopolysaccharide, and glycolipid metabolism with minimal sample preparation. METHODS: We created a single chromatographic method for separating free glycans and glycolipids in their native form, using an amide column and high pH conditions. We used this glycomic profiling method both in untargeted analyses of patient and control urines using LC ion-mobility high-resolution MS (biomarker discovery), and targeted analyses of urine, serum, and dried blood spot samples by LC-MS/MS (clinical validation). RESULTS: Untargeted glycomic profiling revealed twenty biomarkers that could identify and subtype mucopolysaccharidoses. We incorporated these with known oligosaccharide and glycolipid biomarkers into a rapid test that identifies at least 27 lysosomal storage disorders, including oligosaccharidoses, mucopolysaccharidoses, sphingolipidoses, glycogen storage disorders, and congenital disorders of glycosylation and de-glycosylation. In a validation set containing 115 urine samples from patients with lysosomal storage disorders, all were unambiguously distinguished from normal controls, with correct disease subtyping for 88% (101/115) of cases. Glucosylsphingosine was reliably elevated in dried blood spots from Gaucher disease patients with baseline resolution from galactosylsphingosine. CONCLUSION: Glycomic profiling by liquid chromatography mass spectrometry identifies a range of lysosomal storage disorders. This test can be used in clinical evaluations to rapidly focus a diagnosis, as well as to clarify or support additional gene sequencing and enzyme studies.
Authors: Barbara K Burton; Joel Charrow; George E Hoganson; Darrell Waggoner; Brad Tinkle; Stephen R Braddock; Michael Schneider; Dorothy K Grange; Claudia Nash; Heather Shryock; Rebecca Barnett; Rong Shao; Khaja Basheeruddin; George Dizikes Journal: J Pediatr Date: 2017-07-17 Impact factor: 4.406
Authors: Patricia L Hall; Christina Lam; John J Alexander; Ghazia Asif; Gerard T Berry; Carlos Ferreira; Hudson H Freeze; William A Gahl; Kim K Nickander; Jon D Sharer; Caroline M Watson; Lynne Wolfe; Kimiyo M Raymond Journal: Mol Genet Metab Date: 2018-03-10 Impact factor: 4.797
Authors: Ashlee R Stiles; Haoyue Zhang; Jian Dai; Patricia McCaw; James Beasley; Catherine Rehder; Dwight D Koeberl; Marie McDonald; Deeksha S Bali; Sarah P Young Journal: Mol Genet Metab Date: 2020-05-03 Impact factor: 4.797
Authors: Eugene P Rhee; Sushrut S Waikar; Casey M Rebholz; Zihe Zheng; Regis Perichon; Clary B Clish; Anne M Evans; Julian Avila; Michelle R Denburg; Amanda Hyre Anderson; Ramachandran S Vasan; Harold I Feldman; Paul L Kimmel; Josef Coresh Journal: Clin J Am Soc Nephrol Date: 2018-12-20 Impact factor: 10.614
Authors: Ana Fernández-Marmiesse; Marcos Morey; Merce Pineda; Jesús Eiris; Maria Luz Couce; Manuel Castro-Gago; Jose Maria Fraga; Lucia Lacerda; Sofia Gouveia; Maria Socorro Pérez-Poyato; Judith Armstrong; Daisy Castiñeiras; Jose A Cocho Journal: Orphanet J Rare Dis Date: 2014-04-25 Impact factor: 4.123
Authors: Susan Elliott; Norman Buroker; Jason J Cournoyer; Anna M Potier; Joseph D Trometer; Carole Elbin; Mack J Schermer; Jaana Kantola; Aaron Boyce; Frantisek Turecek; Michael H Gelb; C Ronald Scott Journal: Mol Genet Metab Date: 2016-05-20 Impact factor: 4.797
Authors: Ramon Bonte; Michiel Bongaerts; Serwet Demirdas; Janneke G Langendonk; Hidde H Huidekoper; Monique Williams; Willem Onkenhout; Edwin H Jacobs; Henk J Blom; George J G Ruijter Journal: Metabolites Date: 2019-11-26
Authors: William F Mueller; Lei Zhu; Brandon Tan; Selina Dwight; Brendan Beahm; Matt Wilsey; Thomas Wechsler; Justin Mak; Tina Cowan; Jake Pritchett; Eric Taylor; Brett E Crawford Journal: J Biochem Date: 2022-02-21 Impact factor: 3.387